Skip to main content

Table 2 Patient survival within each model based on log-rank test of KM

From: Evaluation of models to predict prognosis in patients with advanced hepatocellular carcinoma treated with TACE combined with apatinib

models

N

(N)%

OS

Total

200

100

17.2

HAP score

  

< 0.001

A

47

23.5

23.1

B

49

24.5

19.1

C

49

24.5

14.9

D

55

27.5

12.5

Six-to-twelve

  

< 0.001

≤ 6

40

20

22.5

6–12

109

54.5

18.3

> 12

51

25.5

10.7

Up to seven

  

< 0.001

< 7

99

49.5

22.3

≥ 7

101

50.5

12.3

ALBI grade

  

0.001

1

91

45.5

19.6

2

109

54.5

15.2

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us